Lichter Jay — SEC Form 4 filings
SEC reporting owner CIK 1376355. 7 Form 4 filings on record with FilingPulse; latest filed 2024-10-24.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-05 to 2024-10-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 48 legs across 6 filings — 4,177,995 shares, $205,553,833 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 50.
- Largest priced transaction: sale of 691,525 shares @ $54.75 ($37,860,994) in Janux Therapeutics, Inc., filed 2024-06-05.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | 10% owner | 7 | — | 48 legs · 4,177,995 sh · $205,553,833 | 50 |
Form 4 filings — Lichter Jay
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-10-24 | 4 | Janux Therapeutics, Inc. (JANX) | Option exercise (M): 1,868 @ $17 · Option exercise (M): 778 @ $10.73 · Option exercise (M): 778 @ $13.22 · Option exercise (M): 391 @ $39.80 · Sale (S): 3,815 @ $46.68 · Option exercise (M): 1,868 (derivative) @ $0 · +3 more | EDGAR |
| 2024-10-18 | 4 | Janux Therapeutics, Inc. (JANX) jointly with Avalon Ventures XI, L.P., Avalon BioVentures I, LP, Avalon BioVentures SPV I, L.P. | Sale (S): 60,179 @ $49.69 · Sale (S): 11,657 @ $49.69 · Sale (S): 61,445 @ $49.69 · Sale (S): 29,474 @ $50.61 · Sale (S): 5,710 @ $50.61 · Sale (S): 30,094 @ $50.61 · +27 more | EDGAR |
| 2024-09-30 | 4 | Janux Therapeutics, Inc. (JANX) jointly with Avalon Ventures XI, L.P., Avalon BioVentures I, LP, Avalon BioVentures SPV I, L.P. | Sale (S): 49,497 @ $46.78 · Sale (S): 9,592 @ $46.78 · Sale (S): 50,539 @ $46.78 · Sale (S): 40,803 @ $47.77 · Sale (S): 7,908 @ $47.77 · Sale (S): 41,661 @ $47.77 · +24 more | EDGAR |
| 2024-09-12 | 4 | Janux Therapeutics, Inc. (JANX) jointly with Avalon Ventures XI, L.P., Avalon BioVentures I, LP, Avalon BioVentures SPV I, L.P. | Sale (S): 11,319 @ $46.13 · Sale (S): 2,193 @ $46.13 · Sale (S): 11,557 @ $46.13 · Sale (S): 34,326 @ $46.66 · Sale (S): 6,649 @ $46.66 · Sale (S): 35,047 @ $46.66 · +3 more | EDGAR |
| 2024-09-10 | 4 | Janux Therapeutics, Inc. (JANX) jointly with Avalon Ventures XI, L.P., Avalon BioVentures I, LP, Avalon BioVentures SPV I, L.P. | Sale (S): 108,365 @ $42 · Sale (S): 20,991 @ $42 · Sale (S): 110,644 @ $42 · Option exercise (M): 994 @ $17 · Option exercise (M): 414 @ $10.73 · Option exercise (M): 414 @ $13.22 · +6 more | EDGAR |
| 2024-06-28 | 4 | Janux Therapeutics, Inc. (JANX) | Grant/award (A): 2,500 @ $0 · Grant/award (A): 8,350 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | Janux Therapeutics, Inc. (JANX) | Sale (S): 677,279 @ $54.75 · Sale (S): 131,196 @ $54.75 · Sale (S): 691,525 @ $54.75 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1376355 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →